⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
WVE News
Wave Life Sciences Ltd. Ordinary Shares
Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
globenewswire.com
WVE
Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
WVE
Wave Life Sciences to Present at Upcoming Investor Conferences
globenewswire.com
WVE
Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025
globenewswire.com
WVE
Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025
globenewswire.com
WVE
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
globenewswire.com
WVE
Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
globenewswire.com
WVE